Pictet Asset Management
MLYS icon

Pictet Asset Management’s Mineralys Therapeutics MLYS Stock Holding History

Pictet Asset Management’s Portfolio MLYS Stock Details MLYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.6M Buy
1,430,649
+396,211
+38% +$10.9M 0.04% 387
2026
Q1 		$28M Buy
1,034,438
+181,555
+21% +$5.32M 0.03% 429
2025
Q4 		$31M Sell
852,883
-76,286
-8% -$3.06M 0.03% 418
2025
Q3 		$35.2M Sell
929,169
-338,824
-27% -$7.33M 0.03% 394
2025
Q2 		$17.2M Buy
1,267,993
+53,620
+4% +$777K 0.02% 547
2025
Q1 		$19.3M Buy
+1,214,373
New +$14M 0.02% 505

Other funds holding MLYS

CP
Catalys Pacific Tokyo, Japan $229M AUM 100.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $510M AUM

Pictet Asset Management's MLYS Position: Q2 2026 in Review

Pictet Asset Management increased its Mineralys Therapeutics (MLYS) stake by 38% in Q2 2026, buying an estimated $10.9M and bringing the position to 1,430,649 shares worth $38.6M. The position accounts for 0.04% of the portfolio, ranked #387.

Pictet Asset Management first reported a position in MLYS in Q1 2025 and has held it in 6 quarters since. 58 funds tracked by Wall St. Rank hold MLYS as of Q2 2026.

  • Pictet Asset Management held 1,430,649 shares of Mineralys Therapeutics worth $38.6M as of Q2 2026.
  • Pictet Asset Management bought 396,211 Mineralys Therapeutics shares in Q2 2026, an estimated $10.9M.
  • Mineralys Therapeutics made up 0.04% of Pictet Asset Management's portfolio in Q2 2026, its #387 holding.
  • Pictet Asset Management first reported a position in Mineralys Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 58 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.